Jana Tomisch

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Helicobacter Pylori Infection

Top Venues

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jana Tomisch, Vincent Busse, Francesca Rosato, Olga N Makshakova, Pavel Salavei, Anna-Sophia Kittel, Emilie Gillon, Levin Lataster, Anne Imberty, Ana Valeria Meléndez, Winfried Römer
A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells. Cells 12 (14) (2023)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)
Francesca Rosato, Rajeev Pasupuleti, Jana Tomisch, Ana Valeria Meléndez, Dajana Kolanovic, Olga N Makshakova, Birgit Wiltschi, Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. Journal of translational medicine 20 (1) (2022)